Form 8-K - Current report:
SEC Accession No. 0001493152-25-021513
Filing Date
2025-11-10
Accepted
2025-11-10 16:11:41
Documents
19
Period of Report
2025-11-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 35694
2 EX-99.1 ex99-1.htm EX-99.1 176437
3 GRAPHIC ex99-1_001.jpg GRAPHIC 194381
4 GRAPHIC ex99-1_002.jpg GRAPHIC 196275
5 GRAPHIC ex99-1_003.jpg GRAPHIC 94775
6 GRAPHIC ex99-1_004.jpg GRAPHIC 33047
7 GRAPHIC ex99-1_05.jpg GRAPHIC 1518650
  Complete submission text file 0001493152-25-021513.txt   3206997

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE imdx-20251110.xsd EX-101.SCH 3011
9 XBRL LABEL FILE imdx-20251110_lab.xml EX-101.LAB 34239
10 XBRL PRESENTATION FILE imdx-20251110_pre.xml EX-101.PRE 22356
22 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3692
Mailing Address 2 INTERNATIONAL PLAZA DR., SUITE 510 NASHVILLE TN 37217
Business Address 2 INTERNATIONAL PLAZA DR., SUITE 510 NASHVILLE TN 37217 949-409-7600
Insight Molecular Diagnostics Inc. (Filer) CIK: 0001642380 (see all company filings)

EIN.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37648 | Film No.: 251466311
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)